Search filters

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2).

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 10 September 2015
Author/s

author: Melinda Gooderham  Carle Paul 

Publication date September 10, 2015
Language English
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item